Paper
0
Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial
Authors
Mansoor Mirza,Line Bjørge
Frederik Marmé,René Christensen,Marta Gil-Martín,Annika Auranen,Beyhan Ataseven,María Rubio,Vanda Salutari,Adam Luczak,Ingo Runnebaum,Andrés Redondo,Kristina Lindemann,Fabian Trillsch,M.P. Ginesta,Henrik Roed,J.E. Kurtz,Karen Petersson,Gitte‐Bettina Nyvang
+17 authors
,Jalid SehouliJournal
Published
Dec 9, 2024
Show more
Save
Tip0
TipSave